Page last updated: 2024-12-07

silahexocyclium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

silahexocyclium: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID130169
MeSH IDM0170951

Synonyms (10)

Synonym
gtpl331
silahexocyclium
L001247
cyclohexyl-[(4,4-dimethylpiperazin-4-ium-1-yl)methyl]-hydroxy-phenylsilane
piperazinium, 4-((cyclohexylhydroxyphenylsilyl)methyl)-1,1-dimethyl-
124393-85-7
sila-hexocyclium
4-{[cyclohexyl(hydroxy)phenylsilyl]methyl}-1,1-dimethylpiperazin-1-ium
DTXSID80924795
Q27088801
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1345326Human M2 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
AID1345189Rat M1 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
AID1345465Human M4 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
AID1345343Human M3 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
AID1345543Human M5 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's4 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]